Efficacy and Safety of Rebamipide versus Its New Formulation, AD-203, in Patients with Erosive Gastritis: A Randomized, Double-Blind, Active Control, Noninferiority, Multicenter, Phase 3 Study.

Gut Liver · 2021 · PMC8593495 · PMID 33827990

Europe PMC DOI

hedged sentence

0.0740

closest p · 1.5× alpha

0.0740

boldest claim

The sentences

did not reach statistical significancep=0.074so close (0.05 < p ≤ 0.1)

Furthermore, the proportion of patients with ≥80% drug compliance in the AD-203 group was higher than that in the Mucosta R group (98.7% [226/229] vs 96.0% [216/225]); however, this did not reach statistical significance (p=0.074). 4.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.